A comprehensive genetic analysis identified 17,964 pleiotropic SNPs shared between major cardiovascular diseases and respiratory conditions, revealing extensive genetic overlap between heart and lung disorders. The study analyzed GWAS data covering six cardiovascular diseases (including atrial fibrillation, coronary artery disease, and heart failure) and four respiratory diseases (asthma, COPD, pulmonary fibrosis, and sleep apnea), pinpointing 73 pleiotropic loci and 59 candidate genes enriched in fatty acid metabolism and immune pathways. This genomic landscape helps explain why cardiovascular and respiratory diseases so frequently co-occur in patients. The findings suggest that shared genetic architecture, rather than one disease causing another, primarily drives these comorbidities. Only COPD showed a direct causal relationship with heart failure through Mendelian randomization analysis. These insights could reshape clinical approaches to treating patients with multiple cardiopulmonary conditions, potentially identifying individuals at risk for both disease types based on genetic profiles. However, as this is a preprint awaiting peer review, these extensive genetic correlations require validation. The work represents a significant advance in understanding disease pleiotropy, though practical applications for personalized medicine remain to be developed.